Almac
Almac has been supplying peptides to the research community and for clinical trials for > 20 years. The field of personalised cancer vaccines requires a new manufacturing paradigm to ensure high throughput manufacture of multiple neoantigens in an appropriate timescale to the required quality and regulatory standards. Almac has created a unique offering to meet all of those demands, which can be tailored to meet specific client needs. Think Almac for peptide excellence.
